Cargando…

Epidemiologie von SARS-CoV-2/COVID 19: Aktueller Stand

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a beta coronavirus, which first appeared in 2019 and rapidly spread causing a worldwide pandemic. Here we present a nonsystematic review of the current knowledge on its epidemiological features. The SARS-CoV‑2 replicates mainly in the u...

Descripción completa

Detalles Bibliográficos
Autores principales: Salzberger, B., Buder, F., Lampl, B. T., Ehrenstein, B., Hitzenbichler, F., Holzmann, T., Schmidt, B., Hanses, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Medizin 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7594942/
https://www.ncbi.nlm.nih.gov/pubmed/33144889
http://dx.doi.org/10.1007/s11377-020-00479-y
_version_ 1783601731853090816
author Salzberger, B.
Buder, F.
Lampl, B. T.
Ehrenstein, B.
Hitzenbichler, F.
Holzmann, T.
Schmidt, B.
Hanses, F.
author_facet Salzberger, B.
Buder, F.
Lampl, B. T.
Ehrenstein, B.
Hitzenbichler, F.
Holzmann, T.
Schmidt, B.
Hanses, F.
author_sort Salzberger, B.
collection PubMed
description Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a beta coronavirus, which first appeared in 2019 and rapidly spread causing a worldwide pandemic. Here we present a nonsystematic review of the current knowledge on its epidemiological features. The SARS-CoV‑2 replicates mainly in the upper and lower respiratory tract and is mainly transmitted by droplets and aerosols from asymptomatic and symptomatic infected subjects. The estimate for the basic reproduction number (R0) is between 2 and 3 and the median incubation period is 6 days (range 2–14 days). Similar to the related coronaviruses SARS and Middle East respiratory syndrome (MERS), superspreading events play an important role in spreading the disease. The majority of infections run an uncomplicated course but 5–10% of those infected develop pneumonia or a systemic inflammation leading to hospitalization, respiratory and potentially multiorgan failure. The most important risk factors for a complicated disease course are age, hypertension, diabetes, chronic cardiovascular and pulmonary diseases and immunodeficiency. The current infection fatality rate over all age groups is between 0.5% and 1% and the rate rises after the sixth decade of life. Nosocomial transmission and infections in medical personnel have been reported. A drastic reduction of social contacts has been implemented in many countries with outbreaks of SARS-CoV‑2, leading to rapid reductions in R0. Most interventions have used bundles and which of the measures have been more effective is still unknown. Using mathematical models an incidence of 0.4%–1.8% can be estimated for the first wave in Germany.
format Online
Article
Text
id pubmed-7594942
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Medizin
record_format MEDLINE/PubMed
spelling pubmed-75949422020-10-30 Epidemiologie von SARS-CoV-2/COVID 19: Aktueller Stand Salzberger, B. Buder, F. Lampl, B. T. Ehrenstein, B. Hitzenbichler, F. Holzmann, T. Schmidt, B. Hanses, F. Gastroenterologe Schwerpunkt Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a beta coronavirus, which first appeared in 2019 and rapidly spread causing a worldwide pandemic. Here we present a nonsystematic review of the current knowledge on its epidemiological features. The SARS-CoV‑2 replicates mainly in the upper and lower respiratory tract and is mainly transmitted by droplets and aerosols from asymptomatic and symptomatic infected subjects. The estimate for the basic reproduction number (R0) is between 2 and 3 and the median incubation period is 6 days (range 2–14 days). Similar to the related coronaviruses SARS and Middle East respiratory syndrome (MERS), superspreading events play an important role in spreading the disease. The majority of infections run an uncomplicated course but 5–10% of those infected develop pneumonia or a systemic inflammation leading to hospitalization, respiratory and potentially multiorgan failure. The most important risk factors for a complicated disease course are age, hypertension, diabetes, chronic cardiovascular and pulmonary diseases and immunodeficiency. The current infection fatality rate over all age groups is between 0.5% and 1% and the rate rises after the sixth decade of life. Nosocomial transmission and infections in medical personnel have been reported. A drastic reduction of social contacts has been implemented in many countries with outbreaks of SARS-CoV‑2, leading to rapid reductions in R0. Most interventions have used bundles and which of the measures have been more effective is still unknown. Using mathematical models an incidence of 0.4%–1.8% can be estimated for the first wave in Germany. Springer Medizin 2020-10-29 2020 /pmc/articles/PMC7594942/ /pubmed/33144889 http://dx.doi.org/10.1007/s11377-020-00479-y Text en © Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Schwerpunkt
Salzberger, B.
Buder, F.
Lampl, B. T.
Ehrenstein, B.
Hitzenbichler, F.
Holzmann, T.
Schmidt, B.
Hanses, F.
Epidemiologie von SARS-CoV-2/COVID 19: Aktueller Stand
title Epidemiologie von SARS-CoV-2/COVID 19: Aktueller Stand
title_full Epidemiologie von SARS-CoV-2/COVID 19: Aktueller Stand
title_fullStr Epidemiologie von SARS-CoV-2/COVID 19: Aktueller Stand
title_full_unstemmed Epidemiologie von SARS-CoV-2/COVID 19: Aktueller Stand
title_short Epidemiologie von SARS-CoV-2/COVID 19: Aktueller Stand
title_sort epidemiologie von sars-cov-2/covid 19: aktueller stand
topic Schwerpunkt
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7594942/
https://www.ncbi.nlm.nih.gov/pubmed/33144889
http://dx.doi.org/10.1007/s11377-020-00479-y
work_keys_str_mv AT salzbergerb epidemiologievonsarscov2covid19aktuellerstand
AT buderf epidemiologievonsarscov2covid19aktuellerstand
AT lamplbt epidemiologievonsarscov2covid19aktuellerstand
AT ehrensteinb epidemiologievonsarscov2covid19aktuellerstand
AT hitzenbichlerf epidemiologievonsarscov2covid19aktuellerstand
AT holzmannt epidemiologievonsarscov2covid19aktuellerstand
AT schmidtb epidemiologievonsarscov2covid19aktuellerstand
AT hansesf epidemiologievonsarscov2covid19aktuellerstand